Self-Inflicted Wounds

Key Takeaways

• CJR‑X mandates nationwide joint‑replacement bundled payments by Oct 2027
• Projected $725 M savings over five years, about $200 per episode
• Most original CJR savings came from reduced post‑acute care, not outcomes
• Fee compression drives volume growth and pushes orthopedic practices toward consolidation
• Physician‑owned hospitals could test cost‑efficiency if allowed in TEAM

Pulse Analysis

The Centers for Medicare & Medicaid Services’ CJR‑X proposal marks a watershed moment for joint‑replacement reimbursement. By extending mandatory episode‑based payments to virtually every acute‑care hospital, CMS aims to institutionalize value‑based care that began with the original Comprehensive Joint Replacement model. That earlier program demonstrated modest fiscal gains—about $112 million in two‑year savings—largely by steering patients away from skilled‑nursing facilities. However, the new rule’s projected $725 million savings over five years translates to less than $200 per procedure, a stark reduction that raises questions about the marginal benefit of expanding bundled payments when post‑acute cost cuts have largely been exhausted.

Compounding the modest savings outlook is the broader economic context of orthopedic surgery. Medicare’s inflation‑adjusted reimbursement for hip and knee replacements has fallen 55% since 2000, now hovering near $1,160 per episode, including 90‑day postoperative care. This fee compression incentivizes higher volumes and fuels consolidation as independent practices seek economies of scale. The shift toward outpatient sites and the rise of physician‑owned hospitals further complicate the landscape. An RFI embedded in the CJR‑X rule asks whether these hospitals should join the Medicare TEAM program, offering a rare chance to empirically assess whether physician‑owned facilities truly deliver cost efficiencies or merely cherry‑pick healthier patients.

Critics argue that the administrative burden of CJR‑X outweighs its fiscal upside and suggest a simpler experiment: restore baseline reimbursement for independent orthopedic groups while tracking episode costs and outcomes through existing registries. Such a voluntary, data‑driven pilot could illuminate whether higher fees curb consolidation and improve access without the heavy regulatory overhead of a 230‑page rulebook. If successful, the approach could deliver net Medicare savings, preserve practice autonomy, and provide a clearer roadmap for sustainable value‑based care in orthopedics.